These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7498361)

  • 1. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
    Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
    Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimer- and oligomerization of the erythropoietin receptor by disulfide bond formation and significance of the region near the WSXWS motif in intracellular transport.
    Miura O; Ihle JN
    Arch Biochem Biophys; 1993 Oct; 306(1):200-8. PubMed ID: 8215404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction through the receptor for erythropoietin.
    Ihle JN; Quelle FW; Miura O
    Semin Immunol; 1993 Oct; 5(5):375-89. PubMed ID: 8260653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biological properties of erythropoietin in Xenopus laevis.
    Nogawa-Kosaka N; Hirose T; Kosaka N; Aizawa Y; Nagasawa K; Uehara N; Miyazaki H; Komatsu N; Kato T
    Exp Hematol; 2010 May; 38(5):363-72. PubMed ID: 20193733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
    Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
    J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refolding, purification, and characterization of human erythropoietin binding protein produced in Escherichia coli.
    Johnson DL; Middleton SA; McMahon F; Barbone FP; Kroon D; Tsao E; Lee WH; Mulcahy LS; Jolliffe LK
    Protein Expr Purif; 1996 Feb; 7(1):104-13. PubMed ID: 9172774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor.
    Yoshimura A; Zimmers T; Neumann D; Longmore G; Yoshimura Y; Lodish HF
    J Biol Chem; 1992 Jun; 267(16):11619-25. PubMed ID: 1317872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human erythropoietin receptor.
    Winkelmann JC
    Int J Cell Cloning; 1992 Sep; 10(5):254-61. PubMed ID: 1453011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay detects a potential soluble form of the erythropoietin receptor in human plasma.
    Harris KW; Winkelmann JC
    Am J Hematol; 1996 May; 52(1):8-13. PubMed ID: 8638628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional characterization of erythropoietin receptor of the goldfish (Carassius auratus L.).
    Katakura F; Katzenback BA; Belosevic M
    Dev Comp Immunol; 2014 Aug; 45(2):191-8. PubMed ID: 24657210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.
    Livnah O; Johnson DL; Stura EA; Farrell FX; Barbone FP; You Y; Liu KD; Goldsmith MA; He W; Krause CD; Pestka S; Jolliffe LK; Wilson IA
    Nat Struct Biol; 1998 Nov; 5(11):993-1004. PubMed ID: 9808045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimerization of the erythropoietin receptor transmembrane domain in micelles.
    Ebie AZ; Fleming KG
    J Mol Biol; 2007 Feb; 366(2):517-24. PubMed ID: 17173930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor-binding subunit essential for tyrosine phosphorylation and proliferation.
    Ronco LV; Doyle SE; Raines M; Park LS; Gasson JC
    J Immunol; 1995 Apr; 154(7):3444-53. PubMed ID: 7897225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family.
    Middleton SA; Johnson DL; Jin R; McMahon FJ; Collins A; Tullai J; Gruninger RH; Jolliffe LK; Mulcahy LS
    J Biol Chem; 1996 Jun; 271(24):14045-54. PubMed ID: 8662939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction.
    Philo JS; Aoki KH; Arakawa T; Narhi LO; Wen J
    Biochemistry; 1996 Feb; 35(5):1681-91. PubMed ID: 8634300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin receptor binds to Friend virus gp55 through other membrane components.
    Kishi A; Chiba T; Sugiyama M; Machide M; Nagata Y; Amanuma H; Taira H; Katsumata T; Todokoro K
    Biochem Biophys Res Commun; 1993 May; 192(3):1131-8. PubMed ID: 8507186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
    Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
    J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The WSAWS motif is C-hexosylated in a soluble form of the erythropoietin receptor.
    Furmanek A; Hess D; Rogniaux H; Hofsteenge J
    Biochemistry; 2003 Jul; 42(28):8452-8. PubMed ID: 12859190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.